Diagnostic methods in sepsis: The need of speed

Revista da Associacao Medica Brasileira

Volumn 58, Issue 4, 2012, Pages 498-504

  Coelho, Fernando Rodrigues ^a   Martins, Joilson Oliveira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Methods; Sepsis

Indexed keywords

EID: 84866080619     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302012000400024     Document Type: Review

References (80)

1. Suffredini AF, Munford RS. Novel therapies for septic shock over the past 4 decades. JAMA. 2011;306:194-9.
2. Mangia CM, Kissoon N, Branchini OA, Andrade MC, Kopelman BI, Carcillo J. Bacterial sepsis in Brazilian children: a trend analysis from 1992 to 2006. PLoS One. 2011;6:e14817.
3. Booker E. Sepsis, severe sepsis, and septic shock: current evidence for emergency department management. Emerg Med Pract. 2011;13:1-22.
4. Hecksher CA, Lacerda HR, Maciel MA. Characteristics and outcomes of patients treated with drotrecogin alpha and other interventions of the "surviving sepsis" campaign in clinical practice. Rev Bras Ter Intensive. 2008;20:135-43.
5. Pizzolatti ML, Moritz RD, Andrade J. Analysis of knowledge among emergency medicine physicians about systemic inflammatory responses syndrome (SIRS), sepsis, severe sepsis and septic shock definitions criteria. Rev Bras Ter Intensive. 2004;16:210-4.
6. Schefold JC, Hasper D, Jörres A. Organ crosstalk in critically ill patients: hemofiltration and immunomodulation in sepsis. Blood Purif. 2009;28:116-23.
7. Sales-Júnior JAL, David CM, Hatum R, Souza PCSP, Japiassú A, Pinheiro CTS, et al. An epidemiological study of sepsis in intensive care units. Sepsis Brazil Study. Rev Bras Ter Intensive. 2006;18:9-17.
8. Rosolem MM, Rabello LS, Lisboa T, Caruso P, Costa RT, Leal JV, et al. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care. 2012;27(3):301-7.
9. Salluh JI, Rabello LS, Rosolem MM, Soares M, Bozza FA, Verdeal JC, et al. The impact of coagulation parameters on the outcomes of patiet alents with severe community-acquired pneumonia requiring intensive care unit admission. J Crit Care. 2011;26:496-501.
10. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian Sepsis Epidemiological Study. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care. 2004; 8:R251-R26060.
11. Lin J, Lee DS, Chase JG, Hann CE, Lotz T, Wong XW. Stochastic modelling of insulin sensitivity variability in critical care. Biomedical Signal Processing & Control. 2006;1:229-42.
12. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.
13. Villar J, Flores C, Perez-Mendez L. Genetic determinants of survival in sepsis and acute lung injury. Minerva Anestesiol. 2008;74:341-5.
14. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Conference: definition for sepsis and organ failure and guidelines for the use for innovative therapies in sepsis. Chest. 1992;101:1644-1655.
15. Kellum JA, Angus DC. Genetic variation and risk of sepsis. Minerva Anestesiol. 2003;69:245-53.
16. Elias AC, Matsuo T, Grion CM, Cardoso LT, Verri PH. Incidence and risk factors for sepsis in surgical patients: a cohort study. J Crit Care. 2012;27(2):159-66.
17. Shiramizo SC, Marra AR, Durão MS, Paes ÂT, Edmond MB, Pavão dos Santos OF. Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One. 2011;6:e26790.
18. Dahaba AA, Metzler H. Procalcitonins role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiol. 2009;75:447-52.
19. Katz DV, Troster EJ, Vaz FA. Dopamine and kidney in sepsis: a systematic review. Rev Assoc Med Bras. 2003;49:317-25.
20. Carvalho PRA, Trotta EA. Avanços no diagnóstico e tratamento da sepse. J Pediatr. 2003;79:S195-S204.
21. Salles MJ, Sprovieri SR, Bedrikow R, Pereira AC, Cardenuto SL, Azevedo PR, et al. Systemic inflammatory response syndrome/sepsis-review and terminology and physiopathology study. Rev Assoc Med Bras. 1999;45:86-92.
22. Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med. 2008;29:591-603.
23. Xing K, Murthy S, Liles WC, Singh JM. Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Crit Care. 2012;16:R7.
24. Chew MS, Ihrman L, During J, Bergenzaun L, Ersson A, Unden J, et al. Extravascular lung water index improves the diagnostic accuracy of lung injury in patients with shock. Crit Care. 2012;16:R1.
25. Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA. 2011;306:2614-5.
26. Becker JU, Theodosis C, Jacob ST, Wira CR, Groce NE. Surviving sepsis in lowincome and middle-income countries: new directions for care and research. Lancet Infect Dis. 2009;9:577-82.
27. Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm. 2002;15:S3-8.
28. Oliveira C, Xavier RA, Anjos-Vallota E, Martins JO, Silveira VL, Gonçalves LR, et al. Effect of plant neutrophil elastase inhibitor on cell migration, adhesion and cytokine release on inflammatory conditions. Br J Pharmacol. 2010;161:899-910.
29. Oliveira WR, Cavassani SS, Maganhin CC, Carbonel AA, Simões MJ, Simões RS, et al. Histomorphologic and respiratory aspects of acute lung injury in rats induced by experimental sepsis and under pentoxifylline treatment. Rev Assoc Med Bras. 2009;55:127-31.
30. Costantini TW, Deree J, Martins JO, Loomis W, Bansal V, Coimbra R. A novel fluid resuscitation strategy modulates pulmonary transcription factor activation after hemorrhagic shock. Clinics. 2010;65:621-8.
31. Sunahara KK, Martins JO. Alveolar macrophages in diabetes: friends or foes? J Leukoc Biol. 2012;91(6):871-6.
32. Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med. 2012;40:43-9.
33. Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. 2007;40:1037-44.
34. Sunahara KKS, Sannomiya P, Martins JO. Briefs on insulin and innate immune response. Cell Physiol Biochem. 2012;29(1-2):1-8.
35. Souza YM, Fontes B, Martins JO, Sannomiya P, Brito GS, Younes RN, et al. Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats. Clinics. 2010;65:195-202.
36. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care. 2011;1:27.
37. Wang Z, Yu Z, Su J, Cao L, Zhao X, Ruan C. Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura: a fatal fulminant syndrome. Clin Appl Thromb Hemost. 2011;17:251-3.
38. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. For the International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-6
39. Claessens YE, Schmidt J, Batard E, Grabar S, Jegou D, Hausfater P, et al. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect. 2010;16:753-60.
40. Ceccon ME, Vaz FA, Diniz EM, Okay TS. Interleukins 6 and C-reactive protein for the diagnosis of late onset sepsis in the newborn infant. Rev Assoc Med Bras. 2006;52:79-85.
41. Hatzistilianou M. Diagnostic and prognostic role of procalcitonin in infections. ScientificWorldJournal. 2010;10:1941-6.
42. Karon B, Scott R, Burritt M, Santrach P. Comparison of lactate values between point-of-care and central laboratory analyzers. Am J Clin Pathol. 2007;128: 168-71.
43. Han J, Martin GS. Does albumin fluid resuscitation in sepsis save lives? Crit Care Med. 2011;39:418-9.
44. Rudiger A, Gasser S, Fischler M, Hornemann T, Von Eckardstein A, Maggiorini M. Comparable increase of B-type natriuretic peptide and aminoterminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006;34:2140-4.
45. Guinard-Barbier S, Grabar S, Chenevier-Gobeaux C, Quinquis L, Schmidt J, Kierzek G, et al. Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis? Biomarkers. 2011;16:355-63.
46. Iapichino G, Marzorati S, Umbrello M, Baccalini R, Barassi A, Cainarca M, et al. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions? Minerva Anestesiol. 2010;76:814-23.
47. Claessens YE, Mathevon T, Kierzek G, Grabar S, Jegou D, Batard E, et al. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Med. 2010;36:799-809.
48. Nguyen HB, Van Ginkel C, Batech M, Banta J, Corbett SW. Comparison of predisposition, insult/infection, response, and organ dysfunction, acute physiology and chronic health evaluation ii, and mortality in emergency department sepsis in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle. J Crit Care. 2011;Oct25. [Epub ahead of print]
49. Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med. 1995;23:1184-93.
50. Hajjar LA, Nakamura RE, de Almeida JP, Fukushima JT, Hoff PM, Vincent JL, et al. Lactate and base deficit are predictors of mortality in critically ill patients with cancer. Clinics. 2011;66:2037-42.
51. Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E, et al. Emergency Medicine Shock Research Network Investigators. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32:35-9.
52. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin AM, Ressler J, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32:1637-42.
53. Simon L, Saint-Louis P, Amre DK, Lacroix J, Gauvin F. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med. 2008;9:407-13.
54. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66:1133-40.
55. Charles PE, Ladoire S, Aho S. et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram-negative or Gram-positive bacteria. BMC Infect Dis. 2008;8:38.
56. Ferreira AM, Sakr Y. Organ dysfunction: general approach, epidemiology, and organ failure scores. Semin Respir Crit Care Med. 2011;32:543-51.
57. Bullen J, Griffiths E, Rogers H, Ward G. Sepsis: the critical role of iron. Microbes Infect. 2000;2:409-15.
58. Lin J, Parente JD, Chase JG, Shaw GM, Blakemore AJ, Lecompte AJ, et al. Development of a model-based clinical sepsis biomarker for critically ill patients. Comput Methods Programs Biomed. 2011;102:149-55.
59. De Oliveira Martins J, Meyer-Pflug AR, Alba-Loureiro TC, Melbostad H, Costa da Cruz JW, Coimbra R, et al. Modulation of lipopolysaccharide-induced acute lung inflammation: Role of insulin. Shock. 2006;25:260-6.
60. Martins JO, Ferracini M, Anger DB, Martins DO, Ribeiro-Jr LF, Sannomiya P, et al. Signaling pathways and mediators in LPS-induced lung inflammation in diabetic rats: role of insulin. Shock. 2009;31:404-9.
61. Martins JO, Ferracini M, Anger DB, Martins DO, Ribeiro-Jr LF, Sannomiya P, et al. Signaling pathways and mediators in LPS-induced lung inflammation in diabetic rats: role of insulin. Shock. 2010;33:76-82.
62. Mackenzie I, Lever A. Management of sepsis. BMJ. 2007;335:929-32.
63. Riedel S, Carroll KC. Blood cultures: key elements for best practices and future directions. J Infect Chemother. 2010;16:301-16.
64. Molina JM, Cordoba J, Ramirez P, Gobernado M. Deteccion automatica de bacterias y hongos en sangre. Enferm Infecc Microbiol Clin. 2008;26:75-80.
65. Ferreira LE, Dalposso K, Hackbarth BB, Gonçalves AR, Westphal GA, França PHC, et al. Molecular panel for detection of sepsis-related microorganisms. Rev Bras Ter Intensiva. 2011;23:36-40.
66. Deree J, Martins JO, Melbostad H, Putnam JG, de Campos T, Hoyt DB, et al. Insights into the regulation of TNF-α production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics. 2008;63:321-8.
67. Anjos-Valotta EA, Martins JO, Oliveira MA, Casolari DA, Britto LR, Tostes RC, et al. Inhibition of tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression in diabetic rats: role of insulin. Inflamm Res. 2006;55:16-22.
68. Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin inhibits LPS-induced signaling pathways in alveolar macrophages. Cell Physiol Biochem. 2008;21:297-304.
69. Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S. Insulin suppresses LPS-induced iNOS and COX-2 expression and NF-kappaB activation in alveolar macrophages. Cell Physiol Biochem. 2008;22:279-86.
70. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699-713.
71. Schuerholz T, Marx G. Management of sepsis. Minerva Anestesiol. 2008;74:181-95.
72. Martins JO, Wittlin BM, Anger DBC, Martins DO, Sannomiya P, Jancar S. Early phase of allergic airway inflammation in diabetic rats: role of insulin on the signaling pathways and mediators. Cell Physiol Biochem. 2010;26:739-48.
73. Rosário AL, Park M, Brunialti MK, Mendes M, Rapozo M, Fernandes D, et al. SvO(2)-guided resuscitation for experimental septic shock: effects of fluid infusion and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress. Shock. 2011;36:604-12.
74. Skrupky LP, Kerby PW, Hotchkiss RS. Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology. 2011;115:1349-62.
75. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood. 2001;98:3800-8.
76. Rubulotta F, Marshall JC, Ramsay G, Nelson D, Levy M, Williams M. Predisposition, insult/infection, response, and organ dysfunction: a new model for staging severe sepsis. Crit Care Med. 2009;37:1329-35.
77. Westh H, Lisby G, Breysse F, Böddinghaus B, Chomarat M, Gant V, et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect. 2005;15:544-51.
78. Couto DO, Peixoto-Júnior AA, Farias JLM, Sales DB, Lima JPA, Rodrigues RS, et al. Gender and mortality in sepsis: do sex hormones impact the outcome? Rev Bras Ter Intensiva. 2011;23:297-303.
79. Siqueira-Batista R, Gomes AP, Calixto-Lima L, Vitorino RR, Perez MCA, Mendonça EG, et al. Sepsis: an update. Rev Bras Ter Intensiva. 2011;23:207-16.
80. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.